Suppr超能文献

在需要长期抗炎治疗的患者中合理使用非甾体抗炎药、环氧化酶-2特异性抑制剂和质子泵抑制剂的指南。

Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy.

作者信息

Dubois R W, Melmed G Y, Henning J M, Laine L

机构信息

Zynx Health Inc., Beverly Hills, CA 90212, USA.

出版信息

Aliment Pharmacol Ther. 2004 Jan 15;19(2):197-208. doi: 10.1111/j.0269-2813.2004.01834.x.

Abstract

AIM

To rationalize decision making around the use of different non-steroidal anti-inflammatory drug (NSAID) treatment strategies in patients with varying degrees of gastrointestinal and cardiovascular risk.

METHODS

The panel comprised nine physicians (three rheumatologists, two internists, two gastroenterologists and two cardiologists) from geographically diverse areas practising in community-based settings (n = 4) and academic institutions (n = 5). A literature review was performed by the authors on the risks, benefits and costs of NSAIDs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitor co-therapy. The RAND/UCLA Appropriateness Method was used to rate 304 clinical scenarios as 'appropriate', 'uncertain' or 'inappropriate'.

RESULTS

In patients with no previous gastrointestinal event and not concurrently on aspirin (low risk), the panel rated the use of an NSAID alone as 'appropriate' for those aged < 65 years, and the use of an NSAID +proton pump inhibitor or cyclo-oxygenase-2-specific inhibitor + proton pump inhibitor as 'inappropriate'. For patients aged > 65 years and at low risk, an NSAID or cyclo-oxygenase-2-specific inhibitor alone was rated as 'uncertain'. For patients with a previous gastrointestinal event or who concurrently received aspirin, an NSAID alone was rated as 'inappropriate', and either a cyclo-oxygenase-2-specific inhibitor or an NSAID +proton pump inhibitor was rated as 'appropriate'. Finally, for patients with a previous gastrointestinal event and on aspirin, an NSAID or cyclo-oxygenase-2-specific inhibitor in conjunction with a proton pump inhibitor was rated as 'appropriate'.

CONCLUSIONS

Clinicians and managed care entities need to balance the risks, benefits and costs of NSAIDs, cyclo-oxygenase-2-specific inhibitors and the prophylactic use of proton pump inhibitors. The guidelines given here can assist this process.

摘要

目的

使针对不同胃肠道和心血管风险程度患者使用不同非甾体抗炎药(NSAID)治疗策略的决策更加合理。

方法

该小组由九名医生组成(三名风湿病学家、两名内科医生、两名胃肠病学家和两名心脏病学家),他们来自不同地理区域,在社区医疗机构(4名)和学术机构(5名)执业。作者对NSAIDs、环氧化酶-2特异性抑制剂和质子泵抑制剂联合治疗的风险、益处和成本进行了文献综述。采用兰德/加州大学洛杉矶分校适宜性方法将304种临床情况评为“适宜”、“不确定”或“不适宜”。

结果

在既往无胃肠道事件且未同时服用阿司匹林的患者(低风险)中,小组认为,对于年龄<65岁的患者,单独使用NSAID是“适宜的”,而使用NSAID+质子泵抑制剂或环氧化酶-2特异性抑制剂+质子泵抑制剂是“不适宜的”。对于年龄>65岁且低风险的患者,单独使用NSAID或环氧化酶-2特异性抑制剂被评为“不确定”。对于既往有胃肠道事件或同时服用阿司匹林的患者,单独使用NSAID被评为“不适宜”,而使用环氧化酶-2特异性抑制剂或NSAID+质子泵抑制剂被评为“适宜”。最后,对于既往有胃肠道事件且正在服用阿司匹林的患者,将NSAID或环氧化酶-2特异性抑制剂与质子泵抑制剂联合使用被评为“适宜”。

结论

临床医生和管理式医疗实体需要平衡NSAIDs、环氧化酶-2特异性抑制剂和质子泵抑制剂预防性使用的风险、益处和成本。此处给出的指南有助于这一过程。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验